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ew Insights Into Fetal
trioventricular Block Using
etal Magnetocardiography*
isa K. Hornberger, MD, Kathryn Collins, MD
an Francisco, California
outine fetal arrhythmia assessment typically involves the
se of echocardiographic modalities that demonstrate me-
hanical events from which electrophysiological events are
nferred (1). While M-mode and Doppler-based techniques
ave been used successfully to diagnose third-degree atrio-
entricular block (AVB), second-degree AVB, and, more
ecently, first-degree AVB, our evaluation has been limited
o atrial and ventricular rates (2–4), gross P-R interval
stimates using atrial-ventricular activity time intervals (5),
nd rarely detected ventricular ectopy. Although fetal elec-
rocardiogram (ECG) has been shown to be more sensitive
han echocardiogram-based techniques in detecting first-
egree AVB in anti–Ro-positive pregnancies (6), it has
imited use in the evaluation of fetal heart rates out of the
ormal range, is more difficult to acquire at 28 to 32 weeks,
nd involves signal averaging, all limiting its clinical
pplication.
See page 77
Fetal magnetocardiography, the magnetic analog of fetal
CG, is at this time the most effective means of assessing
etal rhythms. Through the work of Zhao et al. (7), it has
rovided new insight into the electrophysiological charac-
eristics of fetal AVB. Their observations suggest fetal AVB
ith and without structural heart disease is far more
omplex than previously appreciated with complex changing
hythms and variable atrioventricular conduction in second-
egree AVB, and abnormal QRS waveforms, co-existence
f junctional and ventricular ectopy, and atrial and ventric-
lar rate responsivity in third-degree AVB. Fetal magneto-
ardiography, however, requires a magnetically shielded
acility and is available in very few centers. Furthermore,
hao et al. (7) studied patients for 50 to 100 min at a time,
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.A
From Pediatric Cardiology and the Fetal Treatment Center, University of California at
an Francisco, San Francisco, California.onger duration than is typical of fetal echocardiography.
till, these new observations should prompt a search for
erhaps more practical tools to evaluate electrophysiological
vents in fetal AVB that will ultimately improve the care of
ffected pregnancies.
In normal pregnancies, fetal heart rate variability and
ccelerations associated with fetal activity increase with
estation (8,9) coinciding with maturation of the autonomic
ervous system. In contrast, reduced fetal heart rate vari-
bility and accelerations particularly within lower heart rate
anges (10,11) occur in intrauterine growth restriction and
hronic fetal hypoxemia. This has been used clinically to
dentify the fetus at greatest risk for sudden demise as a
onsequence of an inability to acutely adapt to changing
hysiological conditions. That many fetuses with isolated
VB have atrial and ventricular beat-to-beat variability and
esponsivity (7) suggests similar autonomic control exists, at
east at higher ventricular rates. A ventricular rate of 56
eats/min has been previously identified as a perinatal
ortality risk factor in fetal third-degree AVB (2,3). Zhao
t al. (7) document that while atrial responsivity exits at
entricular rates of 56 beats/min, there is less ventricular
eat-to-beat variability, which does not change even when
ates increase above 56 beats/min with beta sympathomi-
etic therapy. This suggests affected fetuses may be less able
o adapt to acute physiological demands, which could lead
o sudden fetal demise with or without hydrops. Clinically,
his should prompt more frequent assessment, perhaps
n-patent monitoring and even earlier delivery when the
etus with third-degree AVB and ventricular rates of 56
eats/min reaches a viable gestational age.
The outcome of maternal autoantibody-induced AVB
as improved over the past 2 decades (12). However, more
iffuse myocardial inflammation and fibrosis with decreased
yocardial function observed in 15% to 20% of affected
etuses remains an important risk factor for fetal hydrops
nd perinatal mortality and may evolve postnatally (4,13).
hile Zhao et al. (7) did not identify any fetus with reduced
entricular function or endocardiofibroelastosis (often un-
erappreciated by echocardiography [13]), the presence of
ignificant ventricular ectopy and wide QRS escape rhythms
ould be in keeping with more diffuse disease, which may
ave been ameliorated by corticosteroids (12).
Despite improved outcomes in immune-mediated fetal
VB, the perinatal mortality of third-degree AVB and
tructural heart disease remains high, particularly for the
argest subset of affected fetuses with left atrial isomerism
2,14). Lower ventricular rates (2), severe structural heart
isease (15,16), and intrinsic myocardial pathology (16) all
ontribute to the evolution of hydrops in AVB and left atrial
somerism. Sudden fetal demise without hydrops has also
een observed in this subset of fetuses (14). Zhao et al. (7)
ocumented nonreactive, monotonous ventricular rates in
ll fetuses with structural heart disease and third-degree
VB, which likely contributes to the sudden intrauterine
d
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Editorial Comment January 1/8, 2008:85–6eaths. Differences in heart rate variability (7) and response
o terbutaline (17) between maternal autoantibody-induced
VB and AVB with structural heart disease suggest a
undamental difference in the nature of the conduction
ystem in these conditions, which is also supported by
istological observations (18).
Zhao et al. (7) observed the presence of junctional
ctopic tachycardia (JET) in 26% of the fetuses with
hird-degree AVB with and without structural heart
isease, all requiring pacing at birth. While not previ-
usly reported in any fetal series, it has been documented
ostnatally in case reports and small case series (19,20).
illain et al. (19) described patients with third-degree
VB and JET, 5 of whom died suddenly, with autopsy-
onfirmed focal degeneration of the atrioventricular
ode. More recently, Dubin et al. (20) described 5
atients with congenital JET and third-degree AVB
ssociated with maternal anti-Ro or anti-La antibodies (1
rom Zhao et al. [7]). Junctional ectopic tachycardia and
VB may be a spectrum of injury to the atrioventricular
ode where partial injury is associated with enhanced
utomaticity with JET and more complete injury results
n third-degree AVB and slower, nonreactive heart rate
atterns.
How do the findings of Zhao et al. (7) correlate with
rior studies of AVB diagnosed after birth? Earlier investi-
ations on third-degree AVB have focused on minimum,
aximum, and average daily heart rates to identify patients
t higher risk for sudden death and determine indications
or permanent pacing, with no details regarding heart rate
ariability (21,22). In a recent report evaluating 24-h
olters in patients with congenital third-degree AVB,
ukomanovic et al. (21) showed that low maximum and
verage daytime heart rates were important risk factors for
dams-Stokes attacks and heart failure. Junctional ectopic
achycardia and significant ventricular ectopy were not
ocumented. Differences found in the prenatal and post-
atal series could suggest Zhao et al. (7) has captured a
nique window in time in the evolution of AVB. Their
bservations not only identify important predictors of peri-
atal outcome, but also offer insight into the dynamic
isease process of fetal AVB that may no longer exist later
n the disease.
Although we have begun to better understand the com-
lexity of fetal AVB, future work is necessary to fully
lucidate its pathogenesis, improve prenatal counseling,
dentify the pregnancy for which fetal intervention may be
ndicated, and facilitate development of more appropriate
nd effective perinatal and neonatal management strategies.
eprint requests and correspondence: Dr. Lisa K. Hornberger,
ediatric Echocardiography, 505 Parnassus Avenue, UCSF Medical
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